Bioshares Etf Profile

BBP -  USA Etf  

USD 37.35  0.85  2.23%

Market Performance
0 of 100
Odds Of Distress
Over 71
Bioshares Biotech is selling at 37.35 as of the 24th of May 2022; that is -2.23 percent decrease since the beginning of the trading day. The etf's last reported lowest price was 37.33. Bioshares Biotech has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Bioshares Biotech Products are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of April 2022 and ending today, the 24th of May 2022. Click here to learn more.
Under normal market conditions, the fund will invest not less than 80 percent of its assets in component securities of the index. Bioshares Biotech is traded on NYSEArca Exchange in the United States. More on Bioshares Biotech Products

Bioshares Biotech Etf Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Bioshares Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bioshares Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Bioshares Biotech generated a negative expected return over the last 90 days
Bioshares Biotech has high historical volatility and very poor performance
Bioshares Biotech has high likelihood to experience some financial distress in the next 2 years
Bioshares Biotech generated five year return of -1.0%
This fund holds 96.36% of its assets under management (AUM) in equities
Thematic Classification
Currently Active Investing Idea (view all)
Healthcare Funds
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Bioshares Biotech's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellFairly Valued
DescriptionVirtus LifeSci Biotech Products ETF
Inception Date2014-12-16
BenchmarkLifeSci Biotechnology Products Index
Entity TypeRegulated Investment Company
Asset Under Management13.36 Million
Average Trading Valume1,883.8
Asset TypeEquity
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions, LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year End31-Aug
ExchangeNYSE Arca, Inc.
Number of Constituents50.0
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79
Nav Price37.2
Two Hundred Day Average46.45
Average Daily Volume In Three Month1.55k
Fifty Two Week Low34.12
As Of Date11th of May 2022
Average Daily Volume Last 10 Day1.32k
Fifty Two Week High55.28
One Month-19.46%
Fifty Day Average41.19
Three Month-20.12%
Bioshares Biotech Products [BBP] is traded in USA and was established 2014-12-16. The fund is classified under Health category within Virtus family. The entity is thematically classified as Healthcare Funds. Bioshares Biotech currently have 13.54 M in assets under management (AUM). , while the total return for the last 3 years was -5.02%.
Check Bioshares Biotech Probability Of Bankruptcy

Geographic Allocation (%)

Top Bioshares Biotech Products Constituents

Bioshares Biotech Target Price Odds Analysis

What are Bioshares Biotech's target price odds to finish over the current price? Contingent on a normal probability distribution, the odds of Bioshares Biotech jumping above the current price in 90 days from now is about 66.42%. The Bioshares Biotech Products probability density function shows the probability of Bioshares Biotech etf to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Bioshares Biotech has a beta of 0.9954 suggesting Bioshares Biotech Products market returns are highly reactive to returns on the market. As the market goes up or down, Bioshares Biotech is expected to follow. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Bioshares Biotech is significantly underperforming DOW.
  Odds Below 37.35HorizonTargetOdds Above 37.35
33.36%90 days
Based on a normal probability distribution, the odds of Bioshares Biotech to move above the current price in 90 days from now is about 66.42 (This Bioshares Biotech Products probability density function shows the probability of Bioshares Etf to fall within a particular range of prices over 90 days) .

Bioshares Biotech Major Institutional Holders

Institutional Holdings refers to the ownership stake in Bioshares Biotech that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bioshares Biotech's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bioshares Biotech's value.
InstituionSecurity TypeTotal SharesValue
Royal Bank Of CanadaFund Units64.5 K2.8 M
Simplex Trading LlcPut Options9.5 K261 K
Simplex Trading LlcCall Options80024 K
View Bioshares Biotech Diagnostics

Bioshares Biotech Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bioshares Biotech market risk premium is the additional return an investor will receive from holding Bioshares Biotech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bioshares Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Bioshares Biotech's alpha and beta are two of the key measurements used to evaluate Bioshares Biotech's performance over the market, the standard measures of volatility play an important role as well.

Bioshares Biotech Technical Analysis

The output start index for this execution was zero with a total number of output elements of seventeen. Bioshares Biotech Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Bioshares Biotech price patterns.

Bioshares Biotech Against Markets

Picking the right benchmark for Bioshares Biotech etf is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bioshares Biotech etf price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bioshares Biotech is critical whether you are bullish or bearish towards Bioshares Biotech Products at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bioshares Biotech without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Screener Now


Stock Screener

Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

Investing Bioshares Biotech Products

You need to understand the risk of investing before taking a position in Bioshares Biotech. The danger of trading Bioshares Biotech Products is mainly related to its market volatility and ETF specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bioshares Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bioshares Biotech. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bioshares Biotech is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Bioshares Biotech information on this page should be used as a complementary analysis to other Bioshares Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Complementary Tools for Bioshares Etf analysis

When running Bioshares Biotech price analysis, check to measure Bioshares Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioshares Biotech is operating at the current time. Most of Bioshares Biotech's value examination focuses on studying past and present price action to predict the probability of Bioshares Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bioshares Biotech's price. Additionally, you may evaluate how the addition of Bioshares Biotech to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
The market value of Bioshares Biotech is measured differently than its book value, which is the value of Bioshares that is recorded on the company's balance sheet. Investors also form their own opinion of Bioshares Biotech's value that differs from its market value or its book value, called intrinsic value, which is Bioshares Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioshares Biotech's market value can be influenced by many factors that don't directly affect Bioshares Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioshares Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Bioshares Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioshares Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.